Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2026Business Wire • 05/20/26
ATS to Host Fourth Quarter Earnings Call Thursday May 28, 2026, at 8:30 a.m. EasternBusiness Wire • 05/14/26
Genpact Declines 9.4% Since Beating Q1 Earnings & Revenue EstimatesZacks Investment Research • 05/13/26
Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International ConferenceBusiness Wire • 05/11/26
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International ConferenceGlobeNewsWire • 04/30/26
ATS to Participate in the TD Cowen Distinctive Industrials and Infrastructure Services ConferenceBusiness Wire • 03/10/26
4 Industrial Stocks to Buy on Steady Rebound in Manufacturing ActivityZacks Investment Research • 02/03/26
ATS to Host Third Quarter Earnings Call Wednesday February 4, 2026, at 8:30 a.m. EasternBusiness Wire • 01/22/26
ATS to Participate in the UBS Global Industrials and Transportation ConferenceBusiness Wire • 11/24/25